The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation

Ganesan Karthikeyan, Stuart J. Connolly, Mpiko Ntsekhe, Alexander P. Benz, Sumathy Rangarajan, Gayle Lewis, Yan Yun, Sanjib Kumar Sharma, Fathi Maklady, Alaa Elghamrawy, Khawar Kazmi, Tantchou Tchoumi Jacques Cabral, HU Da-yi, Changsheng Ma, Bernard Gitura, Álvaro Avezum, Liesl Zühlke, Peter Lwabi, Abraham Haileamlak, Okechukwu S. Ogah, Pilly Chillo, María Paniagua, Ahmed ElSayed, Antonio Dans, Lillian Gondwe-Chunda, Onkabetse Julia Molefe‐Baikai, Jesús Antonio González-Hermosillo, James Hakim, Albertino Damasceno, Emmanuel Kamanzi, John Musuku, Kairat Davletov, Katherine Connolly, Bongani M. Mayosi, Salim Yusuf